Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy.

Ann Med · 2024 · PMC11385634 · PMID 39247984

Europe PMC DOI

hedged sentence

0.0820

closest p · 1.6× alpha

0.0820

boldest claim

The sentences

borderline significantp = .082so close (0.05 < p ≤ 0.1)

Also, a borderline significant larger proportion of patients had NT-proBNP < 3000 ng/L when diagnosed with ATTRwt in 2020–2022 as compared with those diagnosed in 2017–2019 (68% vs. 57%, p = .082, Figure 1(B) ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.